CompletedPHASE2NCT07568444

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence: A Randomized Controlled Trial (BRIDGE AI 3)

Sponsor: University of Southern California

Trial Details

Condition	Prostate Cancer (Adenocarcinoma), Bladder Cancer, Kidney Cancers, Testis Cancer
Intervention	Pub2Post
Phase	PHASE2
Status	Completed
Participants	120
Est. Completion	22 Jan 2025
Last Updated	6 May 2026

Primary Outcome

Readability Change; Readability Change; Readability Change; Readability Change; Readability Change; Readability Change

Eligibility Criteria

Inclusion Criteria

Provider Participants Inclusion: * Corresponding authors who have been published in the top 10 journals of urology and medicine * All genders * Any profession * 18+ years of age Exclusion: * Anyone under the age of 18 * Participants that have not published in the top 10 journals of urology and medicine

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Phase II Trial Evaluates AI Tool for Improving Patient Communication in Urological Cancers — BRIDGE AI 3 Study Results

The completed BRIDGE AI 3 trial tested whether artificial intelligence can help healthcare providers create more readable patient education materials for urological cancers. Results from this 120-participant study could transform how complex medical information is communicated to patients.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service